Facebook Twitter LinkedIn Google Plus RSS

Protalex completes $2.8M private placement

By ,

Florham Park-based biopharmaceutical company Protalex announced Thursday it has completed a private placement financing in the amount of $2.82 million.

According to the announcement, the placement accredited investors in the form of 471,334 shares of common stock at $6 per share. Proceeds of the financing will be used for working capital purposes, principally to fund ongoing clinical trials and studies and related activities.

Like NJBIZ on Facebook: facebook.com/NJBIZ

Stay informed with free NJBIZ email newsletters >

More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy